Device type · GIM
Tubes, Vacuum Sample, With Anticoagulant
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
GIM
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
456
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Tubes, Vacuum Sample, With Anticoagulant
- Product code
- GIM
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1675
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for GIM
Latest FDA decisions
K240455 · Decided Oct 31, 2024 · 259 days after receipt
Device type: Tubes, Vacuum Sample, With Anticoagulant (GIM) · Laboratory Medicine & Pathology
- BD MiniDraw Capillary Blood Collection System with BD MiniDraw H&H Capillary Blood Collection Tube510(k)
K230493 · Decided Nov 27, 2023 · 277 days after receipt
Device type: Tubes, Vacuum Sample, With Anticoagulant (GIM) · Laboratory Medicine & Pathology
K213670 · Decided Aug 25, 2023 · 641 days after receipt
Device type: Tubes, Vacuum Sample, With Anticoagulant (GIM) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Reports received
456
Received Nov 1, 2025 to Nov 19, 2026. Includes 2 of another or unstated type.
Malfunction reports
453
99% of reports
Injury reports
1
0.2% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 3 | 0 | 0 | 0 |
| Jan 24 | 10 | 0 | 0 | 0 |
| Feb 24 | 9 | 0 | 0 | 0 |
| Mar 24 | 13 | 0 | 0 | 0 |
| Apr 24 | 5 | 0 | 0 | 0 |
| May 24 | 31 | 0 | 0 | 0 |
| Jun 24 | 38 | 0 | 0 | 0 |
| Jul 24 | 40 | 0 | 0 | 0 |
| Aug 24 | 35 | 0 | 0 | 0 |
| Sep 24 | 45 | 0 | 0 | 0 |
| Oct 24 | 19 | 0 | 0 | 0 |
| Nov 24 | 31 | 0 | 0 | 0 |
| Dec 24 | 40 | 0 | 0 | 0 |
| Jan 25 | 43 | 0 | 0 | 0 |
| Feb 25 | 32 | 0 | 0 | 0 |
| Mar 25 | 53 | 0 | 0 | 0 |
| Apr 25 | 114 | 0 | 0 | 0 |
| May 25 | 51 | 0 | 0 | 0 |
| Jun 25 | 53 | 0 | 0 | 0 |
| Jul 25 | 74 | 0 | 0 | 0 |
| Aug 25 | 23 | 0 | 0 | 0 |
| Sep 25 | 72 | 0 | 0 | 0 |
| Oct 25 | 64 | 0 | 0 | 0 |
| Nov 25 | 36 | 0 | 0 | 0 |
| Dec 25 | 37 | 0 | 0 | 0 |
| Jan 26 | 23 | 0 | 0 | 0 |
| Feb 26 | 45 | 0 | 0 | 0 |
| Mar 26 | 14 | 0 | 0 | 0 |
| Apr 26 | 51 | 0 | 0 | 0 |
| May 26 | 36 | 0 | 0 | 0 |
| Jun 26 | 53 | 0 | 0 | 0 |
| Jul 26 | 53 | 0 | 0 | 0 |
| Aug 26 | 36 | 1 | 0 | 0 |
| Sep 26 | 33 | 0 | 0 | 1 |
| Oct 26 | 36 | 0 | 0 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Short Fill194
- Improper Chemical Reaction78
- Device Contamination with Chemical or Other Material75
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions453
- Abscess1
- Biliary Cirrhosis1
4 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Greiner Bio-One North America, Inc.
Z-0408-2026 · Started Aug 8, 2025 · Posted by FDA Oct 28, 2025
Reason given: Blood collection tubes were manufactured with the label applied too high on the tube, which shifted the printed fill level mark upward, which could result in unnecessary sample rejection and repeat collections.
Cause as FDA categorized it: Under Investigation by firm
Greiner Bio-One North America, Inc.
Z-2507-2021 · Started Aug 20, 2021
Reason given: Complaint of tubes clotting due to variation of anticoagulant and/or tubes have low vacuum.
Cause as FDA categorized it: Under Investigation by firm
Greiner Bio-One North America, Inc.
Z-1534-2021 · Started Mar 29, 2021 · Posted by FDA May 6, 2021
Reason given: VACUETTE Blood Collection tube 9NC Coagulation sodium citrate 3.2% may show insufficient draw volume of the tubes, which could produce erroneous results for prothrombin time, activated partial thromboplastin time, and fibrinogen assays.
Cause as FDA categorized it: Process control
6 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.